E-DRUG: E-drug: Tenidap marketed in your country?

e-drug
1

We would like to know in which countries the nonsteroidal anti-inflammatory
drug tenidap is approved for marketing.

An FDA advisory committee has just denied Pfizer's application for this
drug in the USA. Data presented at the advisory committee meeting showed
tenidap to be associated with bone loss. In an unpublished trial, fracture
rate in the rheumatoid arthritis arm was signifcantly higher than the
comparator drug. These are all of the details we have at this time.

Thanks for the help,

Larry D. Sasich, Pharm.D., FASHP
Public Citizen Health Research Group
1600 20th Street NW
Washington, DC 20009
USA
Phone: 202-588-7782
FAX: 202-588-7796
email: lsasich@gwis2.circ.gwu.edu

[Note from the moderator:

Tenidap was not found in Martindale, 29th ed.
I assume TENIDAP is a brandname. We should know what the generic drug name is.

Wilbert Bannenberg, E-drug moderator. email: wilbertb@xs4all.nl ]